SCHEMBL10195360

SCHEMBL10195360

CCc1ccc(Oc2nc3cc4c(cc3s2)OCCO4)cc1C1=C(O)C(C)(C)OC(C)(C)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.37
MAPT P10636 5/20 0.37
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
KMT2A Q03164 8/20 0.36
KDM4E B2RXH2 7/20 0.36
MEN1 O00255 5/20 0.36
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 2/20 0.36
POLB P06746 2/20 0.36
PRNP P04156 1/20 0.36
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
RAD52 P43351 2/20 0.35
GAA P10253 1/20 0.33
HCRTR1 O43613 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10195363 0.85 NPC1 (0.38) NPC1RAB9AALDH1A1SMN1; SMN2HPGD
SCHEMBL10195359 0.85 ATAD2 (0.38) L3MBTL1MAPTNPC1RAB9AKMT2A
SCHEMBL10195291 0.85 EPHX2 (0.34) L3MBTL1MAPTNPC1RAB9AKMT2A
SCHEMBL10195209 0.85 CYP1A2 (0.42) SMN1; SMN2
SCHEMBL10195386 0.84 CTSD (0.34) L3MBTL1SMN1; SMN2CASP3SENP7SENP6
SCHEMBL10195210 0.84 KMT2A (0.35) MAPTNPC1RAB9AKMT2ALMNA
SCHEMBL10195356 0.84 EPHX2 (0.33) MAPTRAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL16351646 0.82 KMT2A (0.39) MAPTNPC1RAB9AKMT2AMEN1
SCHEMBL10195365 0.82 DYRK1A (0.39) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL10195366 0.82 EPHX2 (0.45) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 L3MBTL1 3154/4885MAPT 3785/4885NPC1 4365/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 L3MBTL1 1453/4885MAPT 3903/4885NPC1 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.